| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.
|
J Clin Oncol
|
1999
|
2.22
|
|
2
|
Relationship between age at diagnosis and treatments received by cancer patients.
|
J Am Geriatr Soc
|
1985
|
1.23
|
|
3
|
Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors.
|
J Clin Oncol
|
1985
|
1.22
|
|
4
|
Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
|
Int J Cancer
|
1973
|
1.18
|
|
5
|
Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
|
N Engl J Med
|
1987
|
1.08
|
|
6
|
The influence of patient age on the diagnosis and treatment of lung and colorectal cancer.
|
Arch Intern Med
|
1990
|
1.04
|
|
7
|
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
|
J Clin Oncol
|
1998
|
1.01
|
|
8
|
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
|
Cancer
|
1990
|
0.98
|
|
9
|
Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.
|
Ann Intern Med
|
1985
|
0.93
|
|
10
|
Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.
|
J Clin Oncol
|
1995
|
0.92
|
|
11
|
Differential characteristics of two newly established human breast carcinoma cell lines.
|
Cancer Res
|
1985
|
0.89
|
|
12
|
Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women.
|
Ann Intern Med
|
1986
|
0.85
|
|
13
|
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.
|
J Clin Oncol
|
1989
|
0.83
|
|
14
|
Successful therapy of crystalcryoglobulinemia: a case report.
|
Med Pediatr Oncol
|
1979
|
0.82
|
|
15
|
Human IgG cryoglobulin with tubular crystal structure.
|
Nat New Biol
|
1973
|
0.81
|
|
16
|
A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
|
Cancer Res
|
1979
|
0.81
|
|
17
|
Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
|
Cancer Treat Rep
|
1986
|
0.81
|
|
18
|
Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.
|
Cancer
|
1994
|
0.81
|
|
19
|
Ultrastructure of myeloma cells in a case with crystalcryoglobulinemia.
|
Cancer
|
1977
|
0.79
|
|
20
|
High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial.
|
Cancer
|
1992
|
0.79
|
|
21
|
Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
|
Cancer Treat Rep
|
1976
|
0.79
|
|
22
|
A phase I trial of continuous infusion cisplatin.
|
Cancer
|
1987
|
0.79
|
|
23
|
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group Study.
|
J Clin Oncol
|
1987
|
0.78
|
|
24
|
Phase I study of 5-fluorodeoxyuridine plus cytosine arabinoside infusions in patients with solid tumors.
|
Cancer Treat Rep
|
1979
|
0.78
|
|
25
|
Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
|
Cancer Treat Rep
|
1987
|
0.78
|
|
26
|
Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.
|
NCI Monogr
|
1986
|
0.78
|
|
27
|
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
|
Cancer
|
1981
|
0.77
|
|
28
|
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
|
Cancer
|
1985
|
0.77
|
|
29
|
Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck.
|
Head Neck Surg
|
1986
|
0.77
|
|
30
|
Clinical trial of weekly pyrazofurin.
|
Cancer Treat Rep
|
1979
|
0.76
|
|
31
|
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma.
|
Am J Clin Oncol
|
1990
|
0.76
|
|
32
|
Tamoxifen in advanced prostate cancer: an ECOG pilot study.
|
Prostate
|
1988
|
0.75
|
|
33
|
Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer.
|
NCI Monogr
|
1986
|
0.75
|
|
34
|
Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancer.
|
Cancer Clin Trials
|
1981
|
0.75
|
|
35
|
Effect of low-dose heparin on the platelet count.
|
South Med J
|
1982
|
0.75
|
|
36
|
Phase I trial of high-dose infused zidovudine combined with leucovorin plus fluorouracil.
|
Cancer Invest
|
1995
|
0.75
|
|
37
|
Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
|
Isr J Med Sci
|
1973
|
0.75
|
|
38
|
Pentostatin induces durable remissions in hairy cell leukemia.
|
J Clin Oncol
|
1991
|
0.75
|
|
39
|
The Brown University Cancer and Aging Study: a statewide cooperative investigation. Study provides insights into the appropriate management of cancer in the elderly.
|
R I Med J
|
1988
|
0.75
|
|
40
|
Evaluation of cell-mediated reactivity and serum blocking factors in melanoma patients on chemotherapy.
|
Med Pediatr Oncol
|
1975
|
0.75
|
|
41
|
A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma.
|
Am J Clin Oncol
|
1992
|
0.75
|
|
42
|
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-fluorouracil.
|
Eur J Clin Pharmacol
|
1991
|
0.75
|
|
43
|
Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome.
|
Med Health R I
|
1998
|
0.75
|
|
44
|
A human breast stromal sarcoma cell line with features of malignant cystosarcoma phyllodes.
|
Cancer
|
1988
|
0.75
|
|
45
|
Lung, breast, and colorectal cancer: the relationship between extent of disease and age at diagnosis.
|
J Am Geriatr Soc
|
1988
|
0.75
|
|
46
|
Hemodynamic effects of potentially useful antineoplastic agents.
|
J Natl Cancer Inst
|
1983
|
0.75
|
|
47
|
Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: a phase I study.
|
J Natl Cancer Inst
|
1990
|
0.75
|
|
48
|
Phase I trial of the combination of 6-methylmercaptopurine riboside and 5-fluorouracil.
|
Med Oncol Tumor Pharmacother
|
1988
|
0.75
|
|
49
|
Nude mouse model of the melanosis syndrome.
|
J Natl Cancer Inst
|
1983
|
0.75
|
|
50
|
Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
|
Cancer Res
|
1982
|
0.75
|